[1]
A. Al-Wataify, “EFFICACY AND SAFETY OF DEFERASIROX THERAPY ON β-THALASSEMIA MAJOR PATIENTS IN BABYLON THALASSEMIA CENTER”, JSMC, vol. 3, no. 2, pp. 125–130, Dec. 2013, doi: 10.17656/jsmc.10041.